Socioclinical Phenotyping in Patients With Atherosclerotic Cardiovascular Disease: A Latent Class Analysis

被引:0
|
作者
Kundi, Harun [1 ,2 ]
Hagan, Kobina [1 ]
Yahya, Tamer [1 ]
Sharma, Garima [3 ]
Al-Kindi, Sadeer [1 ,2 ]
Javed, Zulqarnain [1 ]
Nasir, Khurram [1 ,2 ]
机构
[1] Houston Methodist, Ctr Outcomes Res, Div Hlth Equ & Dispar Res, Houston, TX 77030 USA
[2] Houston Methodist, Ctr Outcomes Res, Houston, TX 77030 USA
[3] Johns Hopkins Univ, Dept Med, Div Cardiol, Sch Med, Baltimore, MD USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2024年 / 211卷
关键词
atherosclerotic cardiovascular disease; socioclinical phenotyping; SOCIAL DETERMINANTS; HEART-FAILURE; HEALTH;
D O I
10.1016/j.amjcard.2023.10.067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a common disease population, such as atherosclerotic cardiovascular disease (ASCVD), latent classes may uncover subgroups of patients that can be distinguished by combina-tions of several factors instead of a single factor. In this study, we sought to identify the clinical, demographic, and social subphenotypes of ASCVD using latent class analysis (LCA) and assess the risk of all-cause and cardiovascular mortality across the identified socioclinical classes. LCA is a statistical technique used to uncover hidden class divisions within a set of subjects using a mix of categorical and/or continuous observed variables. Using the National Health Interview Survey between 2013 and 2018, a nationwide self -reported survey, linked to the National Mortality Index, we included participants aged 18 years and older who reported a history of ASCVD in the United States. The main out-come of this study is all-cause and cardiovascular mortality. There were 17,807 patients with a mean (SD) age of 66.9 (13.5) years. In summary, the 3 classes derived from LCA can be described as follows: class 1 is characterized by non-Hispanic White subjects with a low co-morbidity burden, class 2 consists of older subjects with a higher proportion of men, and class 3 includes younger subjects, predominantly non-Hispanic Black and His-panic, with a greater burden of co-morbidities. In the multivariable models, the adjusted hazard ratio with 95% confidence intervals were 1.678 (1.458 to 1.930) in class 2 and 2.255 (1.931 to 2.633) in class 3 (p <0.001) for the all-cause long-term mortality. The ASCVD subphenotype (latent class) of younger, female, non-Hispanic Black or Hispanic subjects with a high burden of co-morbidities and unfavorable social determinants of health was associated with the highest risk of mortality compared with other classes. Our approach may inform future work to understand the heterogeneity among the demographic, clinical, and social risk factors in the ASCVD population and classify the mortality risk based on these key population characteristics. (c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 50 条
  • [41] The current state of management of atherosclerotic cardiovascular disease in dermatomyositis patients
    Zhao, M.
    Williams, K. J.
    Feng, R.
    Werth, V. P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S67 - S67
  • [42] Structural changes in the gut virome of patients with atherosclerotic cardiovascular disease
    Li, Youshan
    Ma, Jie
    Meng, Jinxin
    Li, Shenghui
    Zhang, Yan
    You, Wei
    Sai, Xulin
    Yang, Jianfeng
    Zhang, Shuo
    Sun, Wen
    MICROBIOLOGY SPECTRUM, 2024, 12 (01):
  • [43] Hypoglycemia and Risk of Atherosclerotic Cardiovascular Disease (ascvd) in Patients With Diabetes
    Rana, Jamal S.
    Liu, Jennifer Y.
    Moffet, Howard H.
    Karter, Andrew
    CIRCULATION, 2020, 142
  • [44] Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders
    Agca, R.
    Heslinga, S. C.
    van Halm, V. P.
    Nurmohamed, M. T.
    HEART, 2016, 102 (10) : 790 - 795
  • [45] Colchicine in atherosclerotic cardiovascular disease
    Tucker, Bradley
    Goonetilleke, Neil
    Patel, Sanjay
    Keech, Anthony
    HEART, 2024, 110 (09) : 618 - 625
  • [46] Stress and Atherosclerotic Cardiovascular Disease
    Inoue, Nobutaka
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, 21 (05) : 391 - 401
  • [47] Imaging of atherosclerotic cardiovascular disease
    Sanz, Javier
    Fayad, Zahi A.
    NATURE, 2008, 451 (7181) : 953 - 957
  • [48] Prevention of Atherosclerotic Cardiovascular Disease
    Daniels, Stephen R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (25) : 2786 - 2788
  • [49] Imaging of atherosclerotic cardiovascular disease
    Javier Sanz
    Zahi A. Fayad
    Nature, 2008, 451 : 953 - 957
  • [50] Atherosclerotic cardiovascular disease and antioxidants
    Walzem, RL
    Hansen, RJ
    WINE IN CONTEXT: NUTRITION - PHYSIOLOGY - POLICY, 1996, : 6 - 12